Affiliation:
1. St. Petersburg State Pediatric Medical University
2. Pavlov First Saint Petersburg State Medical University
Abstract
Body composition reflects the dynamic processes in a child’s development. The recommended restrictive diets for patients with advanced chronic kidney disease (CKD) contribute to a high risk of sarcopenic muscle wasting as diagnosed by bioimpedancemetry.The aim of the study. To assess BMI and body composition in children with CKD, to identify features of body composition in patients with different BMI Z-score values.Materials and methods. The physical development of 110 children with CKD of different stages was assessed. Patients were divided into two clusters: Group 1 (92 children) with BMI from 10.95 to 21.5 kg/m2, BMI Z-score did not exceed +2.0 (without obesity); Group 2 (18 children) – BMI from 24.11 to 37.2 kg/m2, Z-score BMI – more than +2.0 (obese). All underwent bioimpedancemetry, the proportion of fat and active cell mass was assessed. The comparison was carried out by nonparametric statistics methods.Results. Changes in body composition were revealed: children without obesity had severe protein-energy deficiency in 7 cases (7.6 %). The difference in the proportion of fat mass in children of different groups, Me [Q1; Q3]: Group 1 – 18.00 % [14.00; 22.00], Group 2 – 35.00 % [21.98; 41.00], (Mann – Whitney U-test: U = 279.5, p = 0.00001). In Group 1, the active cell mass was 53.50 % [51.00; 56.00], in Group 2 – 41.50 % [39.00; 47.00] (U = 174.5, p = 0.000001), there were no significant differences in other parameters of bioimpedancemetry.Conclusions. The proportion of active cell mass is lower in overweight children, with a significant predominance of the proportion of fat mass, which indicates the depletion of protein reserves due to their redistribution and possible insufficient alimentary intake in advanced stages of CKD.
Subject
General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology
Reference29 articles.
1. Stevens PE, Levin A; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013; 158(11): 825-830. doi: 10.7326/0003-4819-158-11-201306040-00007
2. Chronic kidney disease. Clinical guidelines. Age group – children (draft). 2022. URL: https://cr.minzdrav.gov.ru/recomend/713_1 [date of access: 20.12.2022]. (In Russ.).
3. Kanda E, Kashihara N, Matsushita K, Usui T, Okada H, Iseki K, et al. Guidelines for clinical evaluation of chronic kidney disease: AMED research on regulatory science of pharmaceuticals and medical devices. Clin Exp Nephrol. 2018; 22(6): 1446-1475. doi: 10.1007/s10157-018-1615-x
4. Gurina OP, Dement’eva EA, Blinov AE, Varlamova ON, Stepanova AA, Blinov GA. Immunophenotype of lymphocytes in virus-associated glomerulonephritis in children. Sovremennaya pediatriya. Sankt-Peterburg – Belye Nochi – 2018: Materialy konferentsii. Saint Petersburg; 2018: 38-39. (In Russ.).
5. Gurova MM, Romanova TA, Sysoeva NYa, Rubtsova LV, Grevtseva OM, Ivashchenko EV, et al. A case of polycystic disease in the differential diagnosis of diseases occurring with hepatomegaly. Aktual’nye voprosy kompleksnoy reabilitatsii detey: ot teorii k praktike: Sbornik trudov Mezhregional’noy nauchno-prakticheskoy konferentsii, posvyashchennoy 110-letnemu yubileyu GBUZ «Detskiy sanatoriy – Reabilitatsionnyy tsentr «Detskie Dyuny». Saint Peterburg: InformMed Publ.; 2016: 279-284. (In Russ.).